Abbott Laboratories (ABT), a Compelling Story
It has been more than a 100 days since Abbott Laboratories (NYSE:ABT) separated its research-based pharmaceutical business into a newly formed entity named AbbVie Inc (NYSE:ABBV...
Posts Tagged ‘Abbott Laboratories (ABT)’
Abbott Laboratories (ABT), AbbVie Inc (ABBV) & More: Did You Know That This Stock Is Half What It Had Been?
Abbott Laboratories (NYSE:ABT) stock hit a high in October of last year of 72.47, but when the new year hit, the company split in two, spinning its drug assets into AbbVie Inc...
Abbott Laboratories (ABT), Eli Lilly & Co. (LLY) And Why Diabetes Isn’t Good for Health, But It Can Be for Your Portfolio
When I was six years old, something happened to me that I have never forgotten and will probably always live with.
AbbVie Inc (ABBV)’s First Quarter: The Full Story of Humira And The 7 Dwarfs
In its first four months of existence, AbbVie Inc (NYSE:ABBV) rewarded investors with gains of almost 26%. Going into month five, those gains seem likely to increase.
Abbott Laboratories (ABT), Boston Scientific Corporation (BSX), Johnson & Johnson (JNJ): Blame Obamacare for the Medical-Device Sales Slump?
Has anyone noticed a common theme among the first-quarter results for many of the big medical-device companies? In case you missed earnings announcements from Abbott Laboratories...
Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc (ADR) (GSK): Can This New Drug Win Against Established Competitors?
It’s not just about offering a better drug, but it’s also about launching it at the right time in the market.
Theravance Inc (THRX), Elan Corporation, plc (ADR) (ELN), GlaxoSmithKline plc (ADR) (GSK): Biotech Companies Breaking Up
Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into...
Abbott Laboratories (ABT): Yawn All The Way to Retirement With It
After spinning off its pharmaceutical business -- and most of its dividend, essentially -- you may think Abbott Laboratories (NYSE:ABT) is relegated to a boring medical-device...
Biopharma News: Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT)
Editor's Note: Related Tickers: Amarin Corporation plc (ADR) (NASDAQ:AMRN), GlaxoSmithKline plc (ADR) (NYSE:GSK), Abbott Laboratories (NYSE:ABT), Valeant Pharmaceuticals Intl ...
Pfizer Inc. (PFE), Bristol Myers Squibb Co. (BMY), and Alzheimer’s Milkshakes: The Growth of Medical Nutrition
A milkshake is not foremost on most people’s list of treatments for the neurological disorder Alzheimer’s.
Should You Buy Abbott Laboratories (ABT)?
Abbott Laboratories (NYSE:ABT) reported its quarterly earnings on April 17.
Abbott Laboratories (ABT): Three Things You Need to Know in the Wake of Its Earnings
2013 has been a big year for Abbott Laboratories (NYSE:ABT).
Abbott Laboratories (ABT): How Will First Quarter Results Impact This Stock?
Since spinning off AbbVie Inc (NYSE:ABBV) at the beginning of the year, Abbott Laboratories (NYSE:ABT)' stock has done pretty well, rising over 13%.
Abbott Laboratories (ABT): Will This Stock Hit New Highs After Earnings?
On Wednesday, Abbott Laboratories (NYSE:ABT) will release its latest quarterly results.
Medtronic, Inc. (MDT): The One Medical Device Company Buffett Should Buy
You would think that the medical-device sector would be rife with big gainers thanks to an aging population, but it's not quite as simple as that.
Abbott Laboratories (ABT), Stryker Corporation (SYK): Will Obamacare Cost You Your Job?
Is your job in jeopardy because of Obamacare? Staunch advocates of the Patient Protection and Affordable Care Act would say absolutely not.
Could Medtronic, Inc. (MDT), Abbott Laboratories (ABT): This Idea Cut $35 Billion from Health Care Costs?
Take $1 out of every $3 spent on health care, throw it in the garbage can -- and pretty soon those dollars add up to a big amount.
Johnson & Johnson (JNJ): Abbott Laboratories (ABT), Too Cheap to Ignore?
Looking for a cheap stock with name-brand power and a strong, diversified portfolio of products? At first glance, you couldn't do much better than Abbott Laboratories (NYSE:ABT...
Abbott Laboratories (ABT): This Company & Ache Labs: A Perfect Match?
Abbott Laboratories (NYSE:ABT) has begun its new future swimmingly.
Abbott Laboratories (ABT), Eli Lilly & Co. (LLY), Regeneron Pharmaceuticals Inc (REGN): Is Johnson & Johnson (JNJ) a Cash King?
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Abbott Laboratories (ABT), Biogen Idec Inc. (BIIB): Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Help You Retire Rich?
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Pfizer Inc. (PFE), Abbott Laboratories (ABT): Can Johnson & Johnson (JNJ) Turn Around This Lagging Business?
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Arena Pharmaceuticals, Inc. (ARNA) Faces Europe’s Obesity Opportunity: VIVUS Inc. (VVUS)
You can't find a hotter topic in health care than obesity.
Legendary Investor Mason Hawkins Bullish on a Range of Bets: Mondelez International Inc (MDLZ), Abbott Laboratories (ABT), Legg Mason, Inc. (LM)
Mason Hawkins founded Tennessee-based Southeastern Asset Management in 1975.
What’s the Deal With Abbott Laboratories (ABT)? – Johnson & Johnson (JNJ), AbbVie Inc (ABBV)
There were cheers for joy when Abbott Laboratories (NYSE:ABT) announced that it would split itself into two entities -- separating the device and diagnostics businesses from ...
Today’s 3 Worst Stocks: Intuitive Surgical, Inc. (ISRG), Abbott Laboratories (ABT), eBay Inc (EBAY)
Falling slightly, the S&P 500 Index reacted to unexpectedly declining consumer confidence numbers as it headed into the weekend.
Boston Scientific Corporation (BSX) vs. St. Jude Medical, Inc. (STJ): Is Either Stock Worth a Buy?
You wouldn't know that medical device makers Boston Scientific Corporation (NYSE:BSX) and St. Jude Medical, Inc.
Will Merck & Co., Inc. (MRK) Help You Retire Rich? – Abbott Laboratories (ABT), Pfizer Inc. (PFE)
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Will Abbott Laboratories (ABT) Labs Help You Retire Rich? – Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mead Johnson Nutrition CO (MJN)
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Are Antibiotics Dead Weight for Johnson & Johnson (JNJ)?
Johnson & Johnson (NYSE:JNJ) may offer well-known personal care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market-leading therapeutic...
Today’s 3 Worst Stocks: Intuitive Surgical, Inc. (ISRG), AbbVie Inc (ABBV), J.C. Penney Company, Inc. (JCP)
Losing money is always painful.
The Value of Making Drugs: Abbott Laboratories (ABT)
Abbott Laboratories (NYSE:ABT) recently completed a spinoff that created the company AbbVie Inc (NYSE:ABBV). Since this spinoff, both companies have seen a significant rise...
Healthcare Giant’s Giant Drug: Johnson & Johnson (JNJ)
Dow-30 component Johnson & Johnson (NYSE:JNJ) is a giant healthcare company, with exposure to the consumer products, medical devices, and pharmaceuticals arenas.
Is Abbott Laboratories (ABT)’s Universal Microbe Detector a Big Deal?
I think I have uncovered the real reason why Abbott Laboratories (NYSE:ABT) decided to spin off its pharmaceutical division into AbbVie Inc (NYSE:ABBV).
The Better Way To Play Drug Makers: Pfizer Inc. (PFE), Eli Lilly & Co. (LLY)
Analysts wonder if other drug companies will follow in the footsteps of Abbott Laboratories (NYSE:ABT) and spinoff different parts of their business.
Is AbbVie Inc (ABBV) Wasting Your Money?
Stock buybacks are generally considered a bullish signal on Wall Street.
Can Abbott Laboratories (ABT) Grow This Global Business?
Between the patent cliff, taxes, and Europe's meltdown, there's enough information and legislation swirling about to keep concerned shareholders up for days.
Europe, CRM Woes Can’t Subdue Medtronic, Inc. (MDT)’s Earnings
Earnings season is nearing its end after more than a month of investor excitement and disappointment.
Better Dividend: Merck & Co., Inc. (MRK) or Pfizer Inc. (PFE)?
Neither company has a stellar track record when it comes to dividends.
Is Eli Lilly & Co. (LLY) Being Wise About YZ?
It's now more than halfway through the period that Eli Lilly & Co. (NYSE:LLY) has called its "years YZ," a term describing the years spanning from 2011 to 2014.
This Just In: Upgrades and Downgrades – Abbott Laboratories (ABT), Emerson Electric Co. (EMR)
At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and "initiating coverage at neutral." Today, we'll show you ...
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Will There Ever Be an Obesity Drug Blockbuster?
Investors are anxiously waiting for the launch of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai's obesity drug Belviq, which will match up with VIVUS, Inc.
Consider These Big Buys by Todd-Veredus Asset Management: Cisco Systems, Inc. (CSCO) and More
Todd-Veredus Asset Management (TVAM) is an investment adviser based in Louisville, Kentucky with $3.060 billion worth of assets under management as of Dec. 31, 2012.
The Heart of Abbott Laboratories (ABT)’s Future
Between the patent cliff, taxes, and Europe's meltdown, there's enough information and legislation swirling about to keep concerned shareholders up for days.
The Expense Of Diabetes: Is It Worth It? Eli Lilly & Co. (LLY), Novo Nordisk A/S (NVO), Abbott Laboratories (ABT)
With studies showing 33% of Americans with diabetes or pre-diabetes, it is obvious that the industry should be booming.
The Impending Spinoff of a Spinoff: Covidien plc (COV), Pfizer Inc. (PFE), Abbott Laboratories (ABT)
Are you ready for another health-care spinoff? Investors experienced two already in 2013 -- and we're barely into the second month of the year.
The Hole in AbbVie Inc (ABBV)’s 2013
On one hand, you have multibillion-dollar enterprises like AbbVie Inc (NYSE:ABBV) that boast a deep bench of drugs, massive profit margins, and mountains of cash on the balance...
Medtronic, Inc. (MDT), Boston Scientific Corporation (BSX): Here Comes the Medical Device Tax
Ka-ching! That's the sound of the government's cash register after the first tax bill from the Affordable Care Act's medical device tax hit the industry for $97 million this week...
Will Johnson & Johnson (JNJ) Earnings Move the Dow?
With dozens of companies having already reported quarterly results, we're now in the heart of earnings season.
3 High-Yield Pharma Stocks With Major Catalysts
Income investors can find attractive high-yields in the pharmaceutical sector right now. Many major drug makers, including familiar names like Merck & Co., Inc.
